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Modeling Cardiac Pacemaker Malfunctions With the Virtual Heart Model
Abstract
Implantable cardiac devices such as artificial pacemakers deliver therapies according to the timing information
from the heart. Such devices work under the assumptions of perfect sensing, which are: (a) the pacemaker
leads remain in place, and (b) the pacing therapy in one chamber (e.g. atrium) is insulated from the other
chambers (e.g. ventricles). But there are common cases which violate these assumptions and the mechanisms
for imperfect sensing cannot be captured by a simple signal generator. In this paper we use the Penn Virtual
Heart Model (VHM) to investigate the spatial and temporal aspects of the electrical conduction system of the
heart in a closed-loop with a pacemaker model. We utilize the spatial properties of the heart to model the
sensing mechanism, and use clinical cases to show the validity of our sensing model. Such closed-loop
evaluation of the pacemaker operation allows for functional testing of pacemaker software, the development
of new algorithms for rhythm therapy and also serves as a tool for incoming cardiac electrophysiology fellows.
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Abstract—Implantable cardiac devices such as artificial pace-
makers deliver therapies according to the timing information from
the heart. Such devices work under the assumptions of perfect
sensing, which are: (a) the pacemaker leads remain in place, and (b)
the pacing therapy in one chamber (e.g. atrium) is insulated from
the other chambers (e.g. ventricles). But there are common cases
which violate these assumptions and the mechanisms for imperfect
sensing cannot be captured by a simple signal generator. In this
paper we use the Penn Virtual Heart Model (VHM) to investigate
the spatial and temporal aspects of the electrical conduction system
of the heart in a closed-loop with a pacemaker model. We utilize
the spatial properties of the heart to model the sensing mechanism,
and use clinical cases to show the validity of our sensing model.
Such closed-loop evaluation of the pacemaker operation allows
for functional testing of pacemaker software, the development of
new algorithms for rhythm therapy and also serves as a tool for
incoming cardiac electrophysiology fellows.
I.INTRODUCTION
Many artificial implantable pacemaker malfunctions are due
to lead problem. While lead fracture account for a majority of
recent pacemaker recalls, lead displacements occur in over 5.2%
of dual-chamber pacemakers [1]. While most pacing therapy
assume correct sensing and positioning of leads, there is a strong
need to investigate sensing/pacing parameters, algorithms and
software operation in the presence of crosstalk between leads
and lead dislocation. In order to analyze these cases, we use a
spatio-temporal electrophysiological virtual heart model (VHM)
in closed loop operation with a pacemaker model. The VHM has
been described in our recent work [2][3][4]. In this paper, we
use the VHM to analyze the pacemaker function in the presence
of crosstalk and dislocation of leads.
The use of the VHM allows for spatial exploration of lead
placement and parametric exploration for sensing thresholds and
blanking intervals. By extracting conduction parameters from
a patient, electrophysiologists can use the VHM as a tool to
investigate pre-procedure surgical planning. Furthermore, this
can be used as an education tool to train cardiovascular fellows.
Finally, device developers can use the VHM in closed-loop
studies to explore new algorithms to attenuate the effects of
crosstalk and lead displacement.
The paper is organized as follows: We first provide a brief
overview of the VHM and pacemaker models. Following which
we use them to investigate crosstalk between leads and dislo-
cation of leads. Through short case studies we observe how
inappropriate and inefficient therapy is delivered when the
underlying assumptions of perfect sensing and lead placement
are violated. We conclude with a discussion on how this open-
source closed-loop system can be used to further the develop-
ment of cardiac rhythm therapy.
II.VIRTUAL HEART MODEL (VHM) PLATFORM
The coordinated contraction of the atria and the ventricles
are governed by the electrical conduction system of the heart
(Fig. 1(a)). Despite the varieties of the cells, cells in the
heart generate action potential when an electrical potential is
applied to them (Fig. 2(a)), and their action potentials share
similar properties. The action potential can be divided into:
Rest period during which a new and normal action potential
can be initialized, either by potential difference applied to the
cell or by itself for pacemaker cells; Effective Refractory Period
(ERP) which is initialized by the depolarization of the cell,
and during which no new action potential can be initialized;
Relative Refractory Period (RRP) during which a new but
abnormal action potential can be initialized. In the VHM this
behavior is captured using node automaton (Fig. 2(b)). The
timing periods described above are modeled as states with
corresponding timers.
The electrical potential difference caused by the depolariza-
tion of one cell can trigger depolarization of the cells nearby.
This propagation property is captured using path automaton
(Fig. 2(c)). So the electrical conduction system of the heart can
be represented as conduction pathways. Since the refractory
properties along a conduction pathway are governed by the
tissue at both ends of the path [5], one conduction pathway
can be represented as two node automata connected by a
path automata. The electrical conduction system of the heart
represented using node and path automata is shown in Fig. 1(b).
The timing properties of the system are modeled by the timed
automata and the spatial properties of the system is kept by
overlaying the automata onto a 2-D heart anatomy. The VHM
is implemented in Simulink. We were able to use VHM to
simulate different heart conditions in a closed-loop with the
pacemaker model. Some representative heart conditions includ-













High Right Atrium (HRA)
Coronary Sinus (CS)
His Bundle (His)
Right Ventricular Apex (RVA)
(b)
Figure 1. (a) The basic electrical conduction system of the heart. (b)
Corresponding setup of nodes (dots), paths (lines) and probes (shapes)
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Figure 2. (a) Action potential recorded from ventricular tissue. The dashed lines show how action potential morphology changes when a stimulus
is applied early to the tissue and how the corresponding timer values change.(b) Node automaton. (c) Path automaton
Tachycardia (AVNRT), (3) Atrial Flutter (AF), (4) Pacemaker
mode-switch operation and (5) Pacemaker mediated tachycardia.
The VHMs functional output has been validated by the direc-
tor of cardiac electrophysiology in the Philadelphia VA Hospital
and by electrophysiologists in the Hospital of the University
of Pennsylvania. The model generates outputs (Electrograms)
which matches the output of a real heart with same underlying
heart condition when inputs (Programmed pacing) are applied
to it. More detailed description of node and path automaton
implementation and case studies can be found in our previous
papers [2][3][4].
III.PACEMAKER MODEL
In order to show the capability of VHM in Implantable
Cardiac Device Validation & Verification, a simple pacemaker
model is developed. Pacemakers operate in different modes and
these are labeled using a three character system (e.g. xyz). The
first position describes the pacing locations, the second location
describes the sensing locations, and the third position describes
how the pacemaker software responds to sensing. For example,
the DDD mode paces both the atrium and ventricle (D), senses
both (D), and sensing can both activate or inhibit further pacing
(D). We developed a basic DDD pacemaker model according to
to the specification derived from [6].
1. Lower Rate Interval (LRI): The LRI interval starts at a
ventricular sensed or paced event. The LRI interval is the longest
interval between two ventricular events.
2. Upper Rate Interval (URI): The URI interval defines
the shortest interval between a ventricular event and a paced
ventricular event
3. Atrial-Ventricular Interval (AVI): Ventricular pacing
shall occur in the absence of a sensed ventricular event within
the programmed AV delay when the time elapsed after the last
ventricular event is between the programmed LRI and URI.
4. Ventricular Refractory Period (VRP): The VRP is the
time interval following a ventricular event during which no
ventricular sense (VS) can happen.
5. Post Ventricular Atrial Refractory Period (PVARP):
The PVARP is the time interval following a ventricular event
during which no atrial sense (AS) can happen.
According to the five primary specifications of the basic DDD
pacemaker, a Simulink model was designed using temporal
logic. Each component corresponds to a particular specification
and communicates with others using channels. A timing diagram
is shown in Fig. 3. This model can be easily translated into
formal verification tool called UPPAAL for timing verification.
More information about the implementation can be found in [2].
IV.SENSING MODEL
The electrical activity of the heart can be monitored internally
using Electrograms (EGMs) and externally using Electrocardio-
gram (ECG). The EGMs reflect local electrical activities of the
heart tissue while ECG provides a global view of the electrical
activities of the heart. The morphology and timing properties
of these signals are used by both physicians and Implantable
Cardiac Devices to diagnose anomalies in the heart. VHM is a
spatial and temporal model of the heart’s electrical conduction
system thus is capable of generating both signals. The signals
for different heart scenarios can be used for device validation
& verification.
A.. Local electrical activity and Electrogram (EGM)
The EGMs are sensed by electrodes on the pacemaker leads
which are anchored in the inner wall of the heart, which
monitor the local electrical activities of the heart tissue. Timing
differences between impulses and impulse shape can be used by
Implantable Cardiac Devices to diagnose anomaly and deliver
therapy. According to [7], a potential difference is generated
when the activation wavefront passes by the electrode. In our
sensing model, we use probes to represent electrodes. (Fig. 1(b))
The locations of the activation wavefronts are calculated from
the locations of the path automata and their current timer values.
The amplitude of EGM decreases when the activation wavefront
moves away from the probe. We assume the decrease factor is a
Gaussian function related to the distance between the activation
wavefront and the probe. The potential difference caused by an
activation wavefront to a probe is the signal strength of the path
multiplied by the decrease factor. The amplitude of EGM from a
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Figure 3. Simulink design of path automata
Figure 4. Crosstalk between pacemaker leads with high sensitivity in the ventricle, adjusted sensitivity and ventricular safety pacing
probe is the sum of potential differences caused by all activation
wavefronts. The bipolar EGM is the subtraction between two
unipolar EGMs. Fig. 5 shows that this probe model captures
timing properties of EGM and the functional shape of the EGM
impulses. The probes can be placed anywhere within the heart
model and generate clinically-relevant EGMs.
B.. Global electrical activity and Electrocardiogram (ECG)
The ECGs are sensed by electrodes placed on the surface (i.e.
skin) of the torso. ECGs are measured along different axis to
provide a global view of the electrical activities of the heart.
The shape, polarity and timing of the signal can be used by
physicians to evaluate heart functions. VHM is a spatial and
temporal model of the electrical conduction system of the heart
so it’s feasible to simulate clinically-relevant ECG signals. Since
the current VHM is 2-D and as a preliminary effort, we only
simulate the basic timing of the P wave and the QRS wave.
From [8] we know that the amplitude of ECG corresponds to
the projection of the heart vector onto the heart axis aligned to
the lead position. In our sensing model, the amplitude of the
ECG is calculated using the distance between the position of
the activation wavefront to the heart axis. The fidelity of the
signal can be improved by extending the VHM to a 3-D model.
V. OVERSENSING AND CROSSTALK
Oversensing is a general term for inappropriate sensing
caused by noise or far-field signals. It’s very common among
pacemaker malfunctions and it may result in failure to pace,
competitive pacing and inappropriate therapy. Crosstalk is a
special case for oversensing which occurs when the pacemaker
stimulus in one chamber is sensed in the other chamber. It
happens when two leads are close to each other or pacing
signal in the other chamber is too strong. It is common that
the ventricular lead is placed in the right ventricle outflow tract,
which is close to the atrium. Fig. 4(a) shows simulated EGMs
from a patient with bradycardia and complete heart block.
During atrial pacing (AP), the pacing signal is sensed by the
Figure 5. The left columns show the placement of probes in relation to the
path; the right columns show the functional EGM
ventricular lead 53 ms after the AP. (Marker 1) It is treated as
ventricular sense (VS) signal and thus inhibit the subsequent
ventricular pacing (VP). This is indicated by no QRS-wave in
the ECG channel. (Marker 2) For a patient with complete heart
block this will cause dangerous ventricular asystole.
Increasing the sensing threshold of the ventricular channel
can prevent false sensing. In Fig. 4(b), the small signals in ven-
tricular EGM are ignored and ventricular pacing are successfully
delivered.
In the pacemaker design, Ventricular Safety Pacing (VSP) is
used to prevent the consequence of crosstalk. If a ventricular
event is sensed within a window shortly after an atrial pacing
(AP), the pacemaker will deliver ventricular pacing (VP) a
short interval (e.g. 110 ms) after the atrial pacing (AP). This
function can ensure the delivery of ventricular pacing while
preventing the pacing-on-T-wave behavior, which may result in
ventricular fibrillation. Fig. 4(c) shows the same heart condition
with pacemaker with VSP. The false ventricular event falls into
the VSP sensing window, which is [30, 80] ms after the AP,
and VP is delivered 110 ms after the AP. Algorithms treating
crosstalk can be evaluated in this closed-loop VHM-Pacemaker
system.
VI.LEAD DISLODGE
Lead displacement affects many patients and can result in
inappropriate or ineffective therapy. Fig. 6(b) shows the simu-
lation result for the pacemaker function when the leads are in
their designated location. From the figure we can observe: 1)
Each P-wave is initialized by an Atrial Pace signal. 2) Each
QRS complex is initiated by a ventricular pacing signal. 3) The
interval between AP and VP is 150 ms, which matches the
programed AVI period.
One common case for lead dislodge is shown in Fig. 7, where
the atrial lead has fallen into the right ventricle outflow tract.
In this case the atrial lead senses from the ventricle rather
than atrium and atrial pacing will initiate a ventricular event.
Fig. 6(c) shows the simulated EGMs in this case. The figure
reveals several facts: 1) No P wave is sensed or tracked (Marker
1). 2) Atrial Pace initiates an abnormal, wide QRS which is
then sensed by the ventricle lead (Marker 2). 3) Intermittent
appearance of VP on QRS 110 ms after the AP. The ventricular
lead can receive signal from: 1) pacing signal sent from the
atrial lead, 2) the intrinsic A-V conduction path. The two path
are shown in Fig. 7 and form a timing race condition. When
the signal from the atrial lead arrives the ventricular lead first, it
will trigger VS. If the intrinsic signal arrives the ventricular lead
during the VSP sensing window (defined in previous section),
it will trigger VSP. Although the pacing is ’safe’ because the
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Figure 6. (a) Top: Lead II ECG signal, Bottom: VHM simulated ECG signal (b) Pacemaker function before lead dislodge. (b) Pacemaker
function after lead dislodge
the damage caused by pacing on depolarized tissue is currently
a matter of much investigation.
The above two cases of crosstalk and lead dislodgement are
examples of spatio-temporal analysis of the pacemaker function
under non-ideal sensing by the device leads. Such closed-loop
investigation will further the development of approaches to
detect and prevent under and over pacing that damage the heart
tissue.
VII.RELATED WORK
Modeling of cardiac arrhythmias in both electrical timing and
electro-mechanical approaches has been an important topic of
research over the past two decades. [9] and [10] have used a
three-dimensional discrete element mesh to model supraventric-
ular tachycardias, while [11] and [12] modeled the activity of
individual ion channels to simulate arrhythmias. These models
were created for research or diagnostic purposes and do not
have the capability to have closed-loop interaction with medical
devices. Medtronic’s Virtual Interactive Patient simulator can
be used in closed-loop operation with real medical devices, but
the sophistication of this signal generator allows it to be used
as a training tool only and not during the testing of device
software itself [13]. [14] also extracted the timing properties of
the cardiac conduction system to model the heart. Their model
was able to do close-loop simulation with pacemaker software
for several clinically-relevant cases and produce template-based
ECG signals. The VHM platform builds upon this modeling
technique but also allows for cardiac device software verification
and interaction with real devices [2][3][4].
VIII.CONCLUSION
As the software-based algorithms used in implantable medical
devices become more complex, the design of bug-free medical
device software is becoming an increasingly difficult problem.
Safety recalls of pacemakers and implantable cardioverter defib-
rillators between 1990 and 2000 affected over 600,000 devices.





Figure 7. Dotted line shows the location where the atrial lead should be
effect continues to increase in frequency [15]. The high-level
diagnostic and therapeutic operations of artificial pacemakers re-
quires a clinically-relevant and interactive testing methodology
to fully validate their functionality. The VHM provides closed-
loop interaction with both medical device hardware and software
implementations. We presented two case studies on lead cross-
talk and lead displacement to demonstrate how this closed-loop
interaction can result in inappropriate and inefficient rhythm
therapy. Such investigation allows for the development of new
timing derangement detection algorithms, techniques for on-line
sensitivity calibration to prevent oversensing and undersensing
and allows the clinician to select more appropriate blanking
intervals for the patient.
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